Editors:
- The relevance of neurotrophins in a variety of diseases ranging from inflammatory pain, to neurodegeneration and metabolic disease is comprehensively reviewed
- The successful pharmacological avenues used for manipulating neurotrophin signalling in disease as well as future perspectives for their modulation is extensively reviewed
- World renowned experts are revealing future perspectives for new therapies based on neurotrophin signalling and their downstream targets
- Includes supplementary material: sn.pub/extras
Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 220)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (19 chapters)
-
Front Matter
-
Neurotrophin Receptors
-
Front Matter
-
-
The Biology of Neurotrophins
-
Front Matter
-
-
Neurotrophins in Pathological Conditions
-
Front Matter
-
About this book
Editors and Affiliations
-
Department of Neuroscience, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany
Gary R. Lewin
-
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, USA
Bruce D. Carter
Bibliographic Information
Book Title: Neurotrophic Factors
Editors: Gary R. Lewin, Bruce D. Carter
Series Title: Handbook of Experimental Pharmacology
DOI: https://doi.org/10.1007/978-3-642-45106-5
Publisher: Springer Berlin, Heidelberg
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer-Verlag Berlin Heidelberg 2014 2014
Hardcover ISBN: 978-3-642-45105-8Published: 08 April 2014
Softcover ISBN: 978-3-662-52089-5Published: 23 August 2016
eBook ISBN: 978-3-642-45106-5Published: 25 March 2014
Series ISSN: 0171-2004
Series E-ISSN: 1865-0325
Edition Number: 1
Number of Pages: VIII, 520
Number of Illustrations: 10 b/w illustrations, 27 illustrations in colour
Topics: Pharmacology/Toxicology, Molecular Medicine, Neurosciences